Macrophages isolated from the peritoneal cavity ofuntreated mice and maintained in tissue culture synthesize and release prostaglandins when challenged with zymosan. These cells also selectively release lysosomal acid hydrolases under the same conditions. The major prostaglandins released into the media are found to be prostaglandins E1, E2 and 6-oxoprostaglandin F1l,, whereas prostaglandin F2a is not detected. Macrophages isolated from mice that have received an intraperitoneal injection of thioglycollate broth are far less responsive to zymosan challenge. These cells require 300,g of zymosan to synthesize and release one-third the amount of prostaglandins released from non-stimulated macrophages exposed to 50,ug of zymosan. In addition, thioglycollate-stimulated macrophages release less than 10% of their lysosomal acid hydrolases when exposed to 300,ug of zymosan whereas non-stimulated cells release approximately 50 % of these enzymes after treatment with 50,ug of zymosan. The zymosan-stimulated synthesis and release of prostaglandins are completely inhibited by indomethacin, whereas the increased selective release of lysosomal acid hydrolases is not affected. Macrophages, unlike fibroblasts, do not synthesize and release prostaglandins when exposed to serum or to bradykinin.
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Mononuclear phagocytes are derived from a bone-marrow stem cell, which proliferates through several morphologically recognizable stages of maturation (Goud et al., 1975) until its progeny are released into the circulation as monocytes. Monocytes in turn leave the circulation and migrate into a large number of organs and tissues of the body where they serve a wide variety of functions (Van Furth, 1975) . It has become clear that in addition to their phagocytic function, first discovered by Metchnikoff, they also influence their pericellular environment through the release of a wide variety of synthesized products (Page et al., 1978; Gordon, 1977) . These include lysozyme (Gordon etal., 1974) , lysosomal acid hydrolases (Davies & Allison, 1976a) , neutral proteinases (Werb & Gordon, 1975a,b; Vassalli & Reich, 1977) , products affecting the proliferation of lymphocytes and other cells (Unanue et al., 1976) , components of the complement system (Colten & Einstein, 1976) , and several others that are reviewed by Page et al. (1978) . Many of these products probably contribute to the roles played by mononuclear phagocytes in maintaining homoeostasis (Allison & Davies, 1975; Davies & Allison, 1976b) .
Studies by other investigators have shown that the phospholipids of mononuclear phagocytes contain a particularly high proportion of their fatty acids as Vol. 176 arachidonate. Arachidonate constitutes 20% of the fatty acids of rabbit alveolar macrophages (Mason et al., 1972) and of human peripheral monocytes (Stossel et al., 1974) . In view of the importance of the oxygenation products of arachidonate in many metabolic processes it was relevant to determine whether or not significant quantities can be synthesized and released by mononuclear phagocytes. Recent studies in our laboratory (Humes et al., 1977) established that this was indeed so, confirming earlier observations by others that mononuclear phagocytes produced prostaglandins (Bray et al., 1974; Gordon et al., 1976) .
In the present studies we describe conditions under which mononuclear phagocytes incorporate [3H]-arachidonate into cellular phospholipids and establish the capacity of certain phagocytic stimuli to cause the synthesis and release of arachidonate oxygenation products as well as to stimulate the selective release of lysosomal enzymes.
Experimental Materials
Male Swiss Webster mice (HLA-SW/ICR SPF) were purchased from Hilltop Lab Animals, Scottdale, PA, U.S.A. M199 medium, pig serum and foetal calf serum were from Grand Island Biological Co., Grand Island, NY, U.S.A. The pig serum and foetal calf serum were inactivated by heating at 56°C for 30min. Nunclon tissue-culture dishes were from Vangard International, Neptune, NJ, U.S.A. [5,6,8,9,11,12,14,15(n) -3H]arachidonic acid (sp. radioactivity 64Ci/mmol), [8,9,11,12,14,15(n) -3H]-eicosatrienoic acid (sp. radioactivity 17.5 Ci/mmol) and [9,10(n) -3H]oleic acid (sp. radioactivity 6.4 Ci/ mmol) were obtained from New England Nuclear, Boston, MA, U.S.A. Zymosan was from ICN, K and K Labs, Plainview, NY, U.S.A., and latex beads (0.8.um diam.) were from Dow Chemicals, Indianapolis, IN, U.S.A. The zymosan particles were suspended in phosphate-buffered saline, boiled and centrifuged three times. The final pellet was suspended in phosphate-buffered saline at a concentration of 20mg/ml and stored frozen. Latex beads were suspended in phosphate-buffered saline, centrifuged at 5000g and washed five times with phosphatebuffered saline. Suspensions of zymosan and latex weie diluted in culture medium and sonicated immediately before addition to the cells. Thioglycollate broth was supplied by BBL, Cockeysville, MD, U.S.A., and dissolved as described. p-Nitrophenyl N-acetyl-fi-D-glucosaminide was from Sigma Chemical Co., St. Louis, MO, U.S.A. Phenolphthalein glucuronide and bradykinin were from Calbiochem, San Diego, CA, U.S.A. Prostaglandins F2., E2 and D2 were from Ono Pharmaceuticals, Osaka, Japan. SG-81 chromatographic paper was from Ace Scientific, Linden, NJ, U.S.A. Silica-gel GF t.l.c. plates were from Analtech, Newark, DE, U.S.A. Nanograde solvents from Mallinkrodt, St. Louis, MO, U.S.A., were used in the radioimmunoassay.
The antisera to prostaglandin F2.r (preparation 101-F) was a gift from Dr. H. Behrman, Yale University, and antiserum to prostaglandin E2 (lot 61-335) was from Miles Laboratories, Elkhart, IN, U.S.A. 6-Oxoprostaglandin F1l and thromboxane B2 were prepared from labelled arachidonic acid by using rat stomach and guinea-pig lung homogenates respectively and were a gift from Dr. E. A. Ham of these laboratories.
Methods
Tissue culture. Macrophages were collected by peritoneal lavage from untreated mice or from mice that had received, 4 days previously, an intraperitoneal injection of 2ml of thioglycollate broth. The lavage medium was M199 containing 100 units of penicillin and streptomycin/ml, 20 units of heparin/ml, and 1 % heat-inactivated pig serum. The cells were plated at 4 x 106-5 x 106 per 60mm culture dish and incubated for 2h at 37°C in 5 % CO2 in air. The non-adherent cells were removed by washing the cell sheet four times with phosphate-buffered saline and the adherent cells were maintained overnight in 4ml of medium M199 plus 10% heat-inactivated pig serum. After 24h the media were removed and the cells were washed twice with 5ml of phosphatebuffered saline. Fresh M199 medium (4ml) containing 1 % heat-inactivated pig serum was added and 1 #Ci of 3H-labelled fatty acid was used.
Harvest of media and cells for prostaglandin and lysosomal hydrolase measurements. At the termination of the experiments, media were collected and divided for subsequent analysis. Then 2 ml of 0.9% NaCl containing 0.1 % Triton X-100 was added to the plates and the lysed cells were removed with a rubber 'policeman'.
Enzyme assays. Lactate dehydrogenase was assayed by determining the rate of oxidation of NADH at A340. N-Acetyl-fl-D-glucurosaminidase was assayed by the method of Woolen et al. (1961) that of authentic 6-oxoprostaglandin Fl,, was cut out and counted. In some experiments with solvent system 1 radioactivity co-chromatographic with both 6-oxoprostaglandin F1, and prostaglandin F2, was cut out and counted. The cellular distribution of incorporated arachidonate was determined by harvesting the cells in 2ml of 0.03M-citric acid followed by lipid extraction. The final residues were dissolved in ethyl acetate/ methanol, applied to SG-81 paper and chromatographed with authentic phospholipid standards in chloroform/methanol/acetic acid/water (50:25:8:4, by vol.). The radioactivity was determined by scanning the chromatograms.
Radioimmunoassay for prostaglandins. The culture media containing released prostaglandins were collected, extracted and prostaglandins ofthe E and F series purified by t.l.c. on silica-gel G plates as described by Humes & Strausser (1974) . Radioimmunoassays for prostaglandins E and F were carried out by the method of Orczyk & Behrman (1972) .
Results
The procedure used to isolate and cultivate cells for these studies is highly reproducible. The cultures have been shown by morphological and functional criteria to be predominantly mononuclear phagocytes. Cells isolated from untreated mice or from thioglycollatetreated mice were strongly adherent, secreted lysozyme, possessed membrane receptors for the Fc portion of immunoglobulin molecules, and were highly phagocytic.
Labelling of cellular phospholipids with [3H] In contrast, in thioglycollate-stimulated cells, the radioactive label was distributed nearly equally between phosphatidylcholine and phosphatidylethanolamine. The label found in these three components represents 99 % of the solvent-extractable radioactivity.
Zymosan-stimulated release of prostaglandins and lysosomal acid hydrolasesfrom macrophages Zymosan causes chronic inflammatory lesions, dominated by macrophages, in mice when injected intramuscularly (Schorlemmer et al., 1977) . This inflammatory stimulus has also been shown to cause the selective release oflysosomal enzymes from mouse peritoneal macrophages maintained in culture (Schorlemmer et al., 1977) . We now show that addition ofzymosan to cultures ofmacrophages stimulates (Fig. 3) . The release of prostaglandins from stimulated macrophages by 300,ug of zymosan was significantly less than that found from unstimulated cells treated with 50Opg of zymosan (Figs. 3a and 3b ). In addition, there was little or no zymosan-stimulated release of N-acetyl-,B-D-glucosaminidase from stimulated cells (Fig. 3c) .
Identification ofreleasedprostaglandins
The identity of the major prostaglandin components released into the medium after incubation with zymosan was determined by chromatography of the 3H-labelled compounds in three different solvent systems, and the identity of prostaglandin E2 was confirmed by radioimmunoassay. Fig. 4 illustrates a typical radioscan of a chromatogram that had separated the various 3H-labelled products found in the culture medium. It shows that the addition of 50,ug of zymosan/ml to unstimulated macrophages prelabelled with [3H]arachidonate caused the release of a variety of 3H-labelled components that separated into six major peaks of radioactivity (Fig. 4b) . In this system, peak 0 co-chromatographs with phospholipids, peak 1 with 6-oxoprostaglandin Fl,, peak 2 with prostaglandin E2, peak 3 does not co-chromatograph with known standards, peak 4 with 12-hydroxyeicosatetraenoate and peak 5 with arachidonate. It should be noted that the amount of material in peak 0 does not appreciably change after the addition of zymosan (Figs. 4a and 4b) .
The cyclo-oxygenase inhibitor indomethacin completely abolished the synthesis of radioactive material corresponding to peaks 1 and 2, but had only a minimal effect on the radioactivity associated with peaks [3] [4] [5] (Fig. 4c) . In the present paper we concern 1978
._ ourselves with the identity of the components associated with peaks 1 and 2. Peak 1. This product, which is synthesized by cultures to which zymosan was added and whose formation is inhibited by indomethacin, has been identified as 6-oxoprostaglandin F1Q, by the following criteria.
(1) It co-chromatographs with authentic 6-oxoprostaglandin Fl, in the three solvent systems described in the Experimental section. (2) evidence that the identity of peak 1 was 6-oxoprostaglandin Fl was obtained from studies where zymosan-stimulated macrophages had been prelabelled with one of three 3H-labelled fatty acids, namely Fig. 4. arachidonate, eicosa-8,11,14-trienoate or oleate. As expected, cells prelabelled with [3H]arachidonate synthesized and released a radioactive product co-chromatographic with 6-oxoprostaglandin Fl. (Fig. 5a ). Since eicosatrienoic acid lacks a double bond between positions C-5 and C-6, cultures labelled with this fatty acid would not be expected to generate 6-oxoprostaglandin F1l. Fig. 5(b) Cells were incubated with luCi of the various 3H-labelled fatty acids for 4h as described in the Experimental section. The culture media were collected and the amounts of the fatty acids incorporated by the cells determined. Fresh medium containing zymosan (100g/ml) was then added and the cells were incubated for an additional 4h. The culture media were again collected and the percentage of radioactivity that was released was calculated. identical chromatographic mobility with prostaglandin B2, thereby confirming that at least this proportion of the component was prostaglandin E2.
(3) The material reacts with antisera to prostaglandin E. In a separate series of experiments the effect of zymosan on the stimulation of prostaglandin synthesis and release was evaluated by radioimmunoassay. Cultures containing 5 x 106 non-stimulated macrophages released 6.1 ±2.2ng of prostaglandin E into their culture medium over a 4h period. Similar cultures incubated with zymosan over the same period of time released 392±23ng of prostaglandin E into their culture medium, representing a stimulation of release of greater than 60-fold. Culture medium containing 50g of zymosan/ml, but not exposed to cells, contained 2.9 ±0.1 ng of prostaglandin E.
Assays for prostaglandin F in the same experiments showed less than 0.5 ng/ml in cultures not exposed to zymosan and 1.3±0.2ng in cultures exposed to zymosan. Since culture medium not exposed to cells contained 1.0±1.3ng of prostaglandin F it is clear that under these experimental conditions non-stimulated peritoneal macrophages do not release prostaglandin F into their culture medium.
Source of arachidonate utilized for prostaglandin synthesis by macrophages We have shown (Table 1 ) that the majority of the
[3H]arachidonate incorporated by non-stimulated macrophages is located in phosphatidylcholine and phosphatidylethanolamine. Since the addition of zymosan causes large increases in the release of 3H-labelled oxygenation products of arachidonate, we questioned whether or not this fatty acid was being released from a specific phospholipid. As shown in Table 1 , zymosan causes a disproportionate loss of radioactivity from phosphatidylcholine with respect to the other two components. In addition, the increase in the percentage of label found in triacylglycerols after zymosan treatment suggests that the released arachidonate is utilized for prostaglandin synthesis or reacylated into triacylglycerols. Vol. 176
Comparison ofthe release ofarachidonate oxygenation products and lysosomal acid hydrolase by macrophages stimulated with different stimuli
We have shown that the addition of the inflammatory particle zymosan to cultured macrophages stimulates the release of large amounts of prostaglandins under identical conditions to those under which the selective release of lysosomal acid hydrolases occurs (Figs. 2 and 3) . It has been reported that particles of similar size such as latex beads, which are readily phagocytosed by macrophages (Michl et al., 1976) , are not inflammatory in mice and do not cause the selective release of lysosomal acid hydrolases from cultured macrophages (Schorlemmer et al., 1977) . We now show that addition of latex to non-stimulated macrophages also fails to stimulate the release of prostaglandins (Fig. 6) . As expected, the addition of 50g of zymosan to the medium caused the release of 6-oxoprostaglandin Fl., prostaglandin E2 and figlucuronidase. In contrast the addition of 320pg of latex beads under identical conditions did not elicit these responses. The latex tas not toxic to the cells as determined by the retention of cytoplasmic lactate dehydrogenase.
Indomethacin inhibits the synthesis of prostaglandin E2 and 6-oxoprostaglandin F1, by macrophages. In contrast, indomethacin did not inhibit the zymosan stimulated release of lysosomal acid hydrolases (Fig. 6) . Macrophages do not synthesize and release prostaglandins when stimulated with agents such as foetal calf serum or bradykinin, which are both known to stimulate the formation of these products by fibrosarcoma cells (Hong & Levine, 1976a) . Table 3 shows that although both zymosan and foetal calf serum cause considerable increases in the pH]arachidonate release from macrophages into culture medium only the former stimulates the synthesis of prostaglandin E2 and 6-oxoprostaglandin F1l. This difference is emphasized by the finding that more arachidonate was released into serumcontaining cultures; this may be accounted for in part by binding of [3H] arachidonate to albumin, as shown by Hong & Levine (1976b) . Bradykinin caused only slight increases in [3H]arachidonate release and no significant increases in 3H-labelled prostaglandin E2 and 6-oxoprostaglandin Fl. synthesis and release.
Discussion
The fatty acids of macrophage phospholipids contain an unusually high proportion of arachi- donate (Mason et al., 1972; Stossel et al., 1974) . Since the oxygenation products of this fatty acid have a wide variety of biological activities (Kuehl, 1974) , it was pertinent to determine whether such substances were synthesized by macrophages under certain conditions. Indeed, prostaglandins of the E and F series had already been detected by radioimmunoassay in the culture medium of human macrophages residing on interuterine contraceptive devices (Myatt et al., 1975) and in the medium of guinea-pig peritoneal exudate cells stimulated with lymphokines (Gordon et al., 1976) . Hong & Levine (1976a,b) have shown that synthesis ofarachidonate oxygenation products can be detected readily in cultures of fibroblasts that have been prelabelled with [3H]arachidonate and subsequently exposed to various stimuli. In the present studies we have utilized this technique and have also used radioimmunoassays to measure prostaglandin synthesis and release by cultured mouse peritoneal macrophages.
Macrophages lavaged from the peritoneum of untreated mice and from thioglycollate-stimulated mice incorporated [3H]arachidonate at approximately the same rate (Fig. 1) . The major labelled phospholipids in both cases were found to be phosphatidylcholine and phosphatidylethanolamine (Table 1) . However, there was a significant decrease in the ratio of labelled phosphatidylcholine to labelled triacylglycerols in stimulated cells compared with unstimulated cells (Table 1) . Others have shown that [3H] arachidonate is incorporated into phospholipids of human platelets (Bills et al., 1976) , methylcholanthrene-transformed Balb/3T3 cells (Pong & Levine, 1976) and heart tissue (Isakson et al., 1976) . Non-stimulated macrophages also incorporated eicosatrienoate, the substrate for prostaglandins of the 1-series, under similar conditions. Oleate, which is not a substrate for prostaglandins, was also incorporated by these cells. On treatment with zymosan, [3H] arachidonate-labelled cells released 5 times the radioactivity of control cultures. The major constituents of the released radioactive material were (Table 1) . The synthesis of prostaglandins by unstimulated macrophages exposed to zymosan coincides with the selective release of lysosomal acid hydrolases (Figs. 2  and 3 ). The release of the two classes of products differed by their sensitivity to inhibition by indomethacin. The synthesis of prostaglandins was completely inhibited by indomethacin at a concentration of lOg/ml. On the other hand this concentration of indomethacin gave no significant inhibition of the release of lysosomal acid hydrolases (Fig. 6) .
The (Allison & Davies, 1975; Schorlemmer et al., 1977) . We confirm this finding in the present paper and further show that zymosan, but not latex, also stimulates the release of prostaglandins from non-stimulated macrophages. In contrast with its effect on platelets (Bills et al., 1976) and fibroblasts (Hong & Levine, 1976a) , bradykinin did not stimulate the release of prostaglandins from macrophages. In addition, unlike fibroblasts, macrophages did not release prostaglandins in response to serum (Table 3) despite the fact that increased amounts of [3H]arachidonate were found in the serum-containing medium.
Macrophages from untreated mice were far more responsive to zymosan treatment than macrophages from thioglycollate-stimulated mice. The release of prostaglandins from stimulated cells exposed to 300,g of zymosan was less than the release from nonstimulated cells exposed to 50ug. In addition, there was little or no release of the lysosomal hydrolases from stimulated cells exposed to zymosan. This observation cannot be explained by a lack of labelled arachidonate available for conversion into prostaglandin. In Fig. 1 , it is shown that stimulated cells took up more of the [3H]arachidonate than nonstimulated cells. Preliminary experiments measuring the amount of zymosan-induced release of arachidonate into the medium in the presence of indomethacin showed that stimulated and non-stimulated cells responded equally, indicating that the diminished capacity of the former cells to synthesize arachidonate oxygenation products is not due to a lack of substrate.
